OPKO HEALTH INC. - COMMON STOCK

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

09 Jan 2024 15:05:28 By Nasdaq GlobeNewswire

OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

08 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

04 Jan 2024 22:31:25 By Nasdaq GlobeNewswire

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

03 Jan 2024 16:05:39 By Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

06 Nov 2023 15:05:01 By Nasdaq GlobeNewswire

New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

02 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

31 Oct 2023 07:00:01 By Nasdaq GlobeNewswire

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

25 Oct 2023 15:25:11 By Nasdaq GlobeNewswire

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

28 Sep 2023 15:08:06 By Nasdaq GlobeNewswire

OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results

03 Aug 2023 15:05:01 By Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

25 Jul 2023 15:05:00 By Nasdaq GlobeNewswire

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

03 May 2023 15:05:01 By Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

25 Apr 2023 15:05:00 By Nasdaq GlobeNewswire

OPKO Health to Hold Virtual R&D Day on March 20, 2023

09 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

08 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

23 Feb 2023 15:05:01 By Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

16 Feb 2023 10:41:10 By Nasdaq GlobeNewswire

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results

08 Nov 2022 15:05:02 By Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022

01 Nov 2022 07:00:01 By Nasdaq GlobeNewswire